Amarantus BioScience Holdings, Inc. (AMBS)

Other OTC - Other OTC Delayed Price. Currency in USD

0.0011

0.0000

(0.00%)

As of 10:22AM EDT. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.0011
Open	0.0010
Bid	0.0000 x 0
Ask	0.0000 x 0
Day's Range	0.0011 - 0.0011
52 Week Range	0.0010 - 0.0090
Volume	7
Avg. Volume	2,021,953

Market Cap	3.222M
Beta (5Y Monthly)	1.73
PE Ratio (TTM)	N/A
EPS (TTM)	-0.0700
Earnings Date	Aug 18, 2016 - Aug 19, 2016
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for AMBS

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

AMARANTUS BIOSCIENCE HLDGS INC
Market Digest: LVS, MRK, NSC, GNRC, DOCUStocks held up on March 13 after some ugly early action that saw the S&P 500 (SPX) down about 1.3%. The index rallied almost 100 points by late morning before selling off over the balance of the day. It was a great session for day traders, but created more agita for the rest of us. The morning low coincided with chart support in the 3,780-3,810 region from the late-December low. On March 14, gains were solid and broad-based.
Rating
Fair Value
Economic Moat
8 days agoArgus Research